Oseltamivir (Tamiflu), a commonly prescribed antiviral drug, mitigates hearing loss in mice

Emma J. Sailor-Longsworth; Richard D. Lutze; Matthew A. Ingersoll; Regina G. Kelmann; Kristina Ly; Duane Currier; Taosheng Chen; Jian Zuo; Tal Teitz

doi:10.1002/ctm2.1803

Clinical and Translational Medicine ›› 2024, Vol. 14 ›› Issue (8) : e1803 DOI: 10.1002/ctm2.1803

LETTER TO THE JOURNAL

Oseltamivir (Tamiflu), a commonly prescribed antiviral drug, mitigates hearing loss in mice

Author information +

History +

PDF

Cite this article

Download citation ▾

Emma J. Sailor-Longsworth, Richard D. Lutze, Matthew A. Ingersoll, Regina G. Kelmann, Kristina Ly, Duane Currier, Taosheng Chen, Jian Zuo, Tal Teitz. Oseltamivir (Tamiflu), a commonly prescribed antiviral drug, mitigates hearing loss in mice. Clinical and Translational Medicine, 2024, 14(8): e1803 DOI:10.1002/ctm2.1803

登录浏览全文

4963

注册一个新账户忘记密码

References

Publishing order | Descend order by publishing year | Descend order by cited within

[1]	Dhillon S. Sodium thiosulfate: pediatric first approval. Paediatr Drugs. 2023;25(2):239-244.

[2]	Ingersoll MA, Malloy EA, Caster LE, et al. BRAF inhibition protects against hearing loss in mice. Sci Adv. 2020;6(49):eabd0561.

[3]	Teitz T, Goktug AN, Chen T, Zuo J. Development of cell-based high-throughput chemical screens for protection against cisplatin-induced ototoxicity. Methods Mol Biol. 2016;1427:419-430.

[4]	Teitz T, Fang J, Goktug AN, et al. CDK2 inhibitors as candidate therapeutics for cisplatin-and noise-induced hearing loss. J Exp Med. 2018;215(4):1187-1203.

[5]	Fernandez K, Wafa T, Fitzgerald TS, Cunningham LL. An optimized, clinically relevant mouse model of cisplatin-induced ototoxicity. Hear Res. 2019;375:66-74.

[6]	Ingersoll MA, Lutze RD, Pushpan CK, et al. Dabrafenib protects from cisplatin-induced hearing loss in a clinically relevant mouse model. JCI Insight. 2023;8(24):e171140.

[7]	Hata K, Koseki K, Yamaguchi K, et al. Limited inhibitory effects of oseltamivir and zanamivir on human sialidases. Antimicrob Agents Chemother. 2008;52(10):3484-3491.

[8]	Gallo K, Goede A, Preissner R, Gohlke BO. SuperPred 3.0: drug classification and target prediction—a machine learning approach. Nucleic Acids Res. 2022;50(W1):W726-W731.

[9]	Davies BE. Pharmacokinetics of oseltamivir: an oral antiviral for the treatment and prophylaxis of influenza in diverse populations. J Antimicrob Chemother. 2010;65(suppl 2):ii5-ii10.

[10]	Nair AB, Jacob S. A simple practice guide for dose conversion between animals and human. J Basic Clin Pharm. 2016;7(2):27-31.

RIGHTS & PERMISSIONS

2024 The Author(s). Clinical and Translational Medicine published by John Wiley & Sons Australia, Ltd on behalf of Shanghai Institute of Clinical Bioinformatics.